Bioequivalence Study of Eszopiclone Tablets, 3 mg Under Fasting Conditions
NCT02322645
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
46
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Eszopiclone Tablets 3 mg
Sponsor
Dr. Reddy's Laboratories Limited